Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Receivables - Other: 2023-2024

Historic Receivables - Other for Abivax (ABVX) over the last 2 years, with Dec 2024 value amounting to $20.5 million.

  • Abivax's Receivables - Other fell 12.26% to $19.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $19.4 million, marking a year-over-year decrease of 12.26%. This contributed to the annual value of $20.5 million for FY2024, which is 23.90% down from last year.
  • Latest data reveals that Abivax reported Receivables - Other of $20.5 million as of FY2024, which was down 23.90% from $26.9 million recorded in FY2023.
  • In the past 5 years, Abivax's Receivables - Other ranged from a high of $26.9 million in FY2023 and a low of $20.5 million during FY2024.
  • Its 2-year average for Receivables - Other is $23.7 million, with a median of $23.7 million in 2024.
  • Data for Abivax's Receivables - Other shows a maximum YoY declined of 23.90% (in 2024) over the last 5 years.
  • Abivax's Receivables - Other (Yearly) stood at $26.9 million in 2023, then decreased by 23.90% to $20.5 million in 2024.